No profile data available.
Natural Capsules Limited (NATCAPSUQ.BO) is a healthcare company in the drug manufacturing contractors industry, based in Bengaluru, India, with about 615 full-time employees.
It reported revenue of 1.64 billion INR for fiscal year 2025, up 8.7% from fiscal year 2024, and net income of 6.17 million INR. In Q3 2026 (the quarter ended December 31, 2025) revenue was 377.46 million INR, down 13.9% from a year before. Its largest business segment, Capsules, brought in 99% of segment revenue in fiscal year 2025; India was the largest region with 69%. Its market capitalization was 1.66 billion INR as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended March 31, 2025; market data as of October 9, 2026.
Natural Capsules Limited engages in the manufacture and sale of hard gelatin and cellulose capsule shells in India and internationally.
Natural Capsules reported 1.64 billion INR in revenue for fiscal year 2025, up 8.7% from 1.51 billion INR in fiscal year 2024. In Q3 2026 revenue was 377.46 million INR.
Capsules, with 1.68 billion INR or 99% of segment revenue in fiscal year 2025. Next: API (1%).
India: 69% of revenue by region in fiscal year 2025, followed by Exports (31%).
1.66 billion INR as of October 9, 2026.
Listed companies of a similar size in the same industry (drug manufacturing contractors) include Nectar Lifesciences Limited (NECLIFE.NS), Oxygenta Pharmaceutical Limited (OXYGENTAPH.BO), Smruthi Organics Limited (SMRUTHIORG.BO), Kimia Biosciences Limited (KIMIABL.BO).